Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system
Crossref DOI link: https://doi.org/10.1007/s11096-024-01728-8
Published Online: 2024-04-17
Published Print: 2024-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lin, Wanlong
Xu, Jiabing
Liao, Yufang
Lin, Xiuxian
Yang, Jianhui
Zhuang, Wei http://orcid.org/0000-0002-1720-8882
Text and Data Mining valid from 2024-04-17
Version of Record valid from 2024-04-17
Article History
First Online: 17 April 2024
Free to read: This content has been made available to all.